Profil
Leslie Meltzer currently works at Apellis Pharmaceuticals, Inc., as Chief Research & Development Officer from 2025.
Dr. Meltzer also formerly worked at Keryx Biopharmaceuticals, Inc., as Vice President-Medical Affairs from 2016 to 2018 and Orchard Therapeutics Plc, as Senior VP-Medical Affairs & Clinical Operations from 2018 to 2021.
Dr. Meltzer received her doctorate degree from Stanford University School of Medicine.
Postes actifs de Leslie Meltzer
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 25/08/2025 |
Anciens postes connus de Leslie Meltzer
| Sociétés | Poste | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/06/2018 |
| ORCHARD THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | - |
Formation de Leslie Meltzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
















